177 related articles for article (PubMed ID: 28975100)
1. Impact of Τh1 and Τh2 cytokines in the progression of idiopathic nephrotic syndrome due to focal segmental glomerulosclerosis and minimal change disease.
Stangou M; Spartalis Μ; Daikidou DV; Kouloukourgiotou T; Sampani E; Lambropoulou IT; Pantzaki A; Papagianni Α; Efstratiadis G
J Nephropathol; 2017 Jul; 6(3):187-195. PubMed ID: 28975100
[TBL] [Abstract][Full Text] [Related]
2. Urinary N-acetyl-beta-glucosaminidase excretion is a marker of tubular cell dysfunction and a predictor of outcome in primary glomerulonephritis.
Bazzi C; Petrini C; Rizza V; Arrigo G; Napodano P; Paparella M; D'Amico G
Nephrol Dial Transplant; 2002 Nov; 17(11):1890-6. PubMed ID: 12401843
[TBL] [Abstract][Full Text] [Related]
3. Comparative differential proteomic analysis of minimal change disease and focal segmental glomerulosclerosis.
Pérez V; López D; Boixadera E; Ibernón M; Espinal A; Bonet J; Romero R
BMC Nephrol; 2017 Feb; 18(1):49. PubMed ID: 28158993
[TBL] [Abstract][Full Text] [Related]
4. Differential chemokine expression in tubular cells in response to urinary proteins from patients with nephrotic syndrome.
Huang Z; Wen Q; Zhou SF; Yu XQ
Cytokine; 2008 May; 42(2):222-233. PubMed ID: 18362077
[TBL] [Abstract][Full Text] [Related]
5. Immunoglobulin G/albumin staining in tubular protein reabsorption droplets in minimal change disease and focal segmental glomerulosclerosis.
Bu L; Mirocha J; Haas M
Nephrol Dial Transplant; 2021 May; 36(6):1016-1022. PubMed ID: 32191308
[TBL] [Abstract][Full Text] [Related]
6. Th1, Th2 and Treg/T17 cytokines in two types of proliferative glomerulonephritis.
Stangou M; Bantis C; Skoularopoulou M; Korelidou L; Kouloukouriotou D; Scina M; Labropoulou IT; Kouri NM; Papagianni A; Efstratiadis G
Indian J Nephrol; 2016; 26(3):159-66. PubMed ID: 27194829
[TBL] [Abstract][Full Text] [Related]
7. Urinary cytokines and steroid responsiveness in idiopathic nephrotic syndrome of childhood.
Woroniecki RP; Shatat IF; Supe K; Du Z; Kaskel FJ
Am J Nephrol; 2008; 28(1):83-90. PubMed ID: 17914249
[TBL] [Abstract][Full Text] [Related]
8. Urinary peptide profiling to differentiate between minimal change disease and focal segmental glomerulosclerosis.
Pérez V; Ibernón M; López D; Pastor MC; Navarro M; Navarro-Muñoz M; Bonet J; Romero R
PLoS One; 2014; 9(1):e87731. PubMed ID: 24498182
[TBL] [Abstract][Full Text] [Related]
9. Molecular and Cellular Mechanisms for Proteinuria in Minimal Change Disease.
Bertelli R; Bonanni A; Caridi G; Canepa A; Ghiggeri GM
Front Med (Lausanne); 2018; 5():170. PubMed ID: 29942802
[TBL] [Abstract][Full Text] [Related]
10. Urinary fibrinogen and renal tubulointerstitial fibrinogen deposition: Discriminating between primary FSGS and minimal change disease.
Wang Y; Zheng C; Xu F; Liu Z
Biochem Biophys Res Commun; 2016 Sep; 478(3):1147-52. PubMed ID: 27539323
[TBL] [Abstract][Full Text] [Related]
11. A Prospective Study on Complement Activation Distinguishes Focal Segmental Glomerulosclerosis from Minimal Change Disease.
Cambier A; Patey N; Royal V; Gougeon F; Genest DS; Brachemi S; Bollée G; Merlen C; Bonnefoy A; Lapeyraque AL; Troyanov S
Kidney Int Rep; 2024 Mar; 9(3):661-670. PubMed ID: 38481495
[TBL] [Abstract][Full Text] [Related]
12. Glomerular tip lesion: a distinct entity within the minimal change disease/focal segmental glomerulosclerosis spectrum.
Stokes MB; Markowitz GS; Lin J; Valeri AM; D'Agati VD
Kidney Int; 2004 May; 65(5):1690-702. PubMed ID: 15086908
[TBL] [Abstract][Full Text] [Related]
13. Cytotoxic T- Lymphocyte Antigen-4 (CTLA4) Gene Expression and Urinary CTLA4 Levels in Idiopathic Nephrotic Syndrome.
Mishra OP; Chhabra P; Narayan G; Srivastava P; Prasad R; Singh A; Abhinay A; Batra VV
Indian J Pediatr; 2019 Jan; 86(1):26-31. PubMed ID: 29968132
[TBL] [Abstract][Full Text] [Related]
14. Urinary proteins from patients with nephrotic syndrome alters the signalling proteins regulating epithelial-mesenchymal transition.
Wen Q; Huang Z; Zhou SF; Li XY; Luo N; Yu XQ
Nephrology (Carlton); 2010 Feb; 15(1):63-74. PubMed ID: 20377773
[TBL] [Abstract][Full Text] [Related]
15. Indications for kidney biopsy in idiopathic childhood nephrotic syndrome.
Alshami A; Roshan A; Catapang M; Jöbsis JJ; Kwok T; Polderman N; Sibley J; Sibley M; Mammen C; Matsell DG;
Pediatr Nephrol; 2017 Oct; 32(10):1897-1905. PubMed ID: 28540445
[TBL] [Abstract][Full Text] [Related]
16. Morphological Features of Minimal Change Disease and Focal Segmental Glomerulosclerosis Using Repeat Biopsy and Parietal Epithelial Cell Marker.
Suzuki T; Kohatsu K; Han W; Watanabe S; Yahagi K; Nakata M; Ueno T; Ichikawa D; Imai N; Shirai S; Koike J; Shibagaki Y
Kidney Dis (Basel); 2020 Mar; 6(2):119-124. PubMed ID: 32309294
[TBL] [Abstract][Full Text] [Related]
17. Serum microRNAs levels in primary focal segmental glomerulosclerosis.
Cai X; Xia Z; Zhang C; Luo Y; Gao Y; Fan Z; Liu M; Zhang Y
Pediatr Nephrol; 2013 Sep; 28(9):1797-801. PubMed ID: 23463342
[TBL] [Abstract][Full Text] [Related]
18. Urinary CD80 is elevated in minimal change disease but not in focal segmental glomerulosclerosis.
Garin EH; Mu W; Arthur JM; Rivard CJ; Araya CE; Shimada M; Johnson RJ
Kidney Int; 2010 Aug; 78(3):296-302. PubMed ID: 20485332
[TBL] [Abstract][Full Text] [Related]
19. Activation of the acute inflammatory phase response in idiopathic nephrotic syndrome: association with clinicopathological phenotypes and with response to corticosteroids.
Roca N; Martinez C; Jatem E; Madrid A; Lopez M; Segarra A
Clin Kidney J; 2021 Apr; 14(4):1207-1215. PubMed ID: 33841866
[TBL] [Abstract][Full Text] [Related]
20. Minimal change disease and idiopathic focal segmental glomerulosclerosis in adults. A quantitative study.
Danilewicz M; Wagrowska-Danilewicz M
Pol J Pathol; 1996; 47(4):209-14. PubMed ID: 9097714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
